Rhenman & Partners Asset Management AB - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$4,974,000
-2.4%
115,0000.0%0.33%
-7.5%
Q3 2021$5,096,000
+19.6%
115,000
+53.3%
0.36%
+23.9%
Q2 2021$4,261,000
+196.7%
75,000
+50.0%
0.29%
+43.8%
Q1 2020$1,436,000
-60.2%
50,0000.0%0.20%
-49.2%
Q4 2019$3,610,000
+28.7%
50,000
+150.0%
0.40%
+12.5%
Q3 2019$2,806,000
-29.2%
20,000
-7.6%
0.35%
-19.3%
Q2 2019$3,962,000
-51.8%
21,639
-58.1%
0.44%
-54.6%
Q1 2019$8,213,000
-37.6%
51,639
-62.4%
0.96%
-36.1%
Q4 2018$13,156,000
-25.3%
137,339
+10.1%
1.50%
-14.8%
Q3 2018$17,619,000
-13.2%
124,739
-3.8%
1.76%
-15.0%
Q2 2018$20,299,000
+32.7%
129,679
+36.5%
2.08%
+10.1%
Q1 2018$15,302,000
-11.5%
95,000
-9.5%
1.89%
-19.2%
Q4 2017$17,283,000
+454.8%
104,930
+109.9%
2.34%
+486.7%
Q3 2017$3,115,000
-21.8%
50,0000.0%0.40%
-30.4%
Q2 2017$3,982,000
-22.9%
50,000
-31.2%
0.57%
-30.1%
Q1 2017$5,164,00072,6590.82%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders